(Q48653812)

English

A Novel Way To Radiolabel Human Butyrylcholinesterase for Positron Emission Tomography through Irreversible Transfer of the Radiolabeled Moiety

scientific article published on 27 June 2016

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

A Novel Way To Radiolabel Human Butyrylcholinesterase for Positron Emission Tomography through Irreversible Transfer of the Radiolabeled Moiety (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

positron emission tomography

1 reference

based on heuristic

inferred from title

Takahiro Higuchi

4

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

author name string

Edgar Sawatzky

1

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

Ehab Al-Momani

2

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

Ryohei Kobayashi

3

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

Samuel Samnick

5

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

Michael Decker

6

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

publication date

27 June 2016

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

11

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

14

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

1540-1550

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

Cholinergic system during the progression of Alzheimer's disease: therapeutic implications

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

The cholinergic system and Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

The cholinergic system in aging and neuronal degeneration

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Cholinergic function and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Neurobiology of butyrylcholinesterase.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-β peptide in mice.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Learning performances and vulnerability to amyloid toxicity in the butyrylcholinesterase knockout mouse

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Colocalization of cholinesterases with beta amyloid protein in aged and Alzheimer's brains

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Butyrylcholinesterase radioligands to image Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Butyrylcholinesterase is associated with β-amyloid plaques in the transgenic APPSWE/PSEN1dE9 mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Butyrylcholinesterase-knockout reduces brain deposition of fibrillar β-amyloid in an Alzheimer mouse model.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Serum butyrylcholinesterase and the risk of future type 2 diabetes: the Kansai Healthcare Study.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Butyrylcholinesterase activity in young men and women: association with cardiovascular risk factors.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Butyrylcholinesterase activity and risk factors for coronary artery disease.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

PET probes for imaging brain acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Alternative approaches for PET radiotracer development in Alzheimer's disease: imaging beyond plaque.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Cholinergic system function and cognition in mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Positron emission tomography: quantitative measurement of brain acetylcholinesterase activity using radiolabeled substrates

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Acetylcholine esterase activity in mild cognitive impairment and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Radiosynthesis and mouse brain distribution studies of [11C] CP-126,998: a PET ligand for in vivo study of acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Binding of 2-[18F]fluoro-CP-118,954 to mouse acetylcholinesterase: microPET and ex vivo Cerenkov luminescence imaging studies

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Synthesis and evaluation of 2-[18F]fluoro-CP-118,954 for the in vivo mapping of acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Synthesis and evaluation of (-)- and (+)-[¹¹C]galanthamine as PET tracers for cerebral acetylcholinesterase imaging

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Pharmacological evaluation of [11C]donepezil as a tracer for visualization of acetylcholinesterase by PET.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Positron emission tomography study of [11C]methyl-tetrahydroaminoacridine (methyl-tacrine) in baboon brain

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

A novel fluorine-18 β-fluoroethoxy organophosphate positron emission tomography imaging tracer targeted to central nervous system acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Quantitative measurement of cerebral acetylcholinesterase using

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Development of a novel fluorine-18 labeled deuterated fluororasagiline ([(18)F]fluororasagiline-D2) radioligand for PET studies of monoamino oxidase B (MAO-B).

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Synthesis and evaluation of [¹⁸F]fluororasagiline, a novel positron emission tomography (PET) radioligand for monoamine oxidase B (MAO-B).

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, 18F-Labeled Deuterated Fluorodeprenyl.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

A Novel Radiotracer for Imaging Monoacylglycerol Lipase in the Brain Using Positron Emission Tomography.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Radiosynthesis and ex vivo evaluation of [(11)C-carbonyl]carbamate- and urea-based monoacylglycerol lipase inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Mapping human brain fatty acid amide hydrolase activity with PET.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

[11C]CURB: Evaluation of a novel radiotracer for imaging fatty acid amide hydrolase by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

PET imaging of fatty acid amide hydrolase with [(18)F]DOPP in nonhuman primates

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Radiosynthesis and evaluation of [¹¹C-carbonyl]-labeled carbamates as fatty acid amide hydrolase radiotracers for positron emission tomography.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Monoamine oxidase: radiotracer development and human studies

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

In vivo studies of acetylcholinesterase activity using a labeled substrate, N-[11C]methylpiperdin-4-yl propionate ([11C]PMP).

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Age-related increases in brain monoamine oxidase B in living healthy human subjects

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Reproducibility of repeated measures of deuterium substituted [11C]L-deprenyl ([11C]L-deprenyl-D2) binding in the human brain.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Radiolabeled cholinesterase substrates: in vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

1-11C-methyl-4-piperidinyl-N-butyrate radiation dosimetry in humans by dynamic organ-specific evaluation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Neuroprotective Tri- and Tetracyclic BChE Inhibitors Releasing Reversible Inhibitors upon Carbamate Transfer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Development and characterization of a promising fluorine-18 labelled radiopharmaceutical for in vivo imaging of fatty acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Synthesis and preclinical evaluation of [11C-carbonyl]PF-04457845 for neuroimaging of fatty acid amide hydrolase.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

11CO2 fixation: a renaissance in PET radiochemistry.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Synthesis and application of isocyanates radiolabeled with carbon-11.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Organic carbamates in drug design and medicinal chemistry

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Irreversible inhibitors of serine, cysteine, and threonine proteases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Molecular Recognition by Cholesterol Esterase of Active Site Ligands: Structure−Reactivity Effects for Inhibition by Aryl Carbamates and Subsequent Carbamylenzyme Turnover†

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of rivastigmine and donepezil on brain acetylcholine levels in acetylcholinesterase-deficient mice.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

7 January 2021

based on heuristic

inferred from DOI database lookup

The butyrylcholinesterase knockout mouse is obese on a high-fat diet

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

7 January 2021

based on heuristic

inferred from DOI database lookup

Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and preliminary evaluation of piperidinyl and pyrrolidinyl iodobenzoates as imaging agents for butyrylcholinesterase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

7 January 2021

based on heuristic

inferred from DOI database lookup

One-pot synthesis of [11C]ureas via triphenylphosphinimines

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CMDC.201600223

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48653812&oldid=2203996489"